It’s like a light switch that can turn off the pain
Diabetic neuropathy is a complication that affects the nerves that connect to the feet. There are 34 million (10.5%) people in the United States living with diabetes, and about 50% of these patients will develop painful diabetic related peripheral neuropathy.
The FDA approval of spinal cord stimulation for peripheral neuropathy pain is a significant milestone in the management of longstanding neuropathic pain. Spinal Cord Stimulation (SCS) offers an effective alternative for patients who have not responded to traditional treatments. and It may provide some permanent type of relief and improved quality of life style.
Several clinical research studies have showed the effectiveness of SCS in managing peripheral neuropathy pain.
Peripheral neuropathy is a common neurological disease characterized by damage to the tiny peripheral nerves in the feet, leading to various sensory nerves causing numbness and burning pain.
Spinal cord stimulation works by masking the pain using a technology called neuromodulation. This involves the delivery of electrical impulses to the spinal cord to interrupt or mask the pain signals before they reach the brain.
The use of SCS for peripheral neuropathy pain has gained significant attention in recent years, with several research studies reporting positive outcomes in terms of pain relief, functional improvement, and overall patient satisfaction.Spinal cord stimulation is a technique that involves the delivery of electrical impulses to the spinal cord to short circuit or mask the pain signals before they can reach the brain.
Peripheral neuropathy can be a debilitating condition characterized by damage to the peripheral nerves, leading to long standing pain that significantly impacts the quality of life. Traditional treatments such as medication and physical therapy usually only help control pain and provide adequate relief 50% of the time, and in only 50% of the people. Spinal cord stimulation (SCS) is now available as a new promising option for managing neuropathic pain effectively almost 100% of the time in almost 100% of the patients.
Patients Say
SEE WHAT